Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard D Sowery

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
The Canadian Journal of Urology|December 8, 2004
Growth characteristics of renal cortical tumors in patients managed by watchful waitingRichard D Sowery, D Robert Siemens
The Journal of Urology|February 16, 2005
Experimental intraprostatic injection of bacillus Calmette-Guerin: a feasibility and safety studyUrszula Kosecka, Richard D Sowery, Alvaro Morales
Current Opinion in Urology|April 7, 2007
Novel targets and approaches in advanced prostate cancerBoris A Hadaschik, Richard D Sowery, Martin E Gleave
Current Urology Reports|January 24, 2007
Therapeutic options in advanced prostate cancer: present and futureRichard D Sowery, Alan I So, Martin E Gleave
The Canadian Journal of Urology|March 9, 2004
Long-term penile incarceration by a metal ring resulting in urethral erosion and chronic lymphedemaRichard D Sowery, Darren T Beiko, Jeremy P W Heaton
The Canadian Journal of Urology|July 4, 2006
Parameters affecting urologic complications after major joint replacement surgeryJason P Izard, Richard D Sowery, Melanie T Jaeger, et al.
International Journal of Cancer|February 2, 2008
Targeting prostate cancer with HTI-286, a synthetic analog of the marine sponge product hemiasterlinBoris A Hadaschik, Susan Ettinger, Richard D Sowery, et al.
BJU International|March 14, 2008
Clusterin knockdown using the antisense oligonucleotide OGX-011 re-sensitizes docetaxel-refractory prostate cancer PC-3 cells to chemotherapyRichard D Sowery, Boris A Hadaschik, Alan I So, et al.
BJU International|April 4, 2008
Paclitaxel and cisplatin as intravesical agents against non-muscle-invasive bladder cancerBoris A Hadaschik, Melanie G ter Borg, John Jackson, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
The Canadian Journal of Urology|December 8, 2004
Growth characteristics of renal cortical tumors in patients managed by watchful waitingRichard D Sowery, D Robert Siemens
The Journal of Urology|February 16, 2005
Experimental intraprostatic injection of bacillus Calmette-Guerin: a feasibility and safety studyUrszula Kosecka, Richard D Sowery, Alvaro Morales
Current Opinion in Urology|April 7, 2007
Novel targets and approaches in advanced prostate cancerBoris A Hadaschik, Richard D Sowery, Martin E Gleave
Current Urology Reports|January 24, 2007
Therapeutic options in advanced prostate cancer: present and futureRichard D Sowery, Alan I So, Martin E Gleave
The Canadian Journal of Urology|March 9, 2004
Long-term penile incarceration by a metal ring resulting in urethral erosion and chronic lymphedemaRichard D Sowery, Darren T Beiko, Jeremy P W Heaton
The Canadian Journal of Urology|July 4, 2006
Parameters affecting urologic complications after major joint replacement surgeryJason P Izard, Richard D Sowery, Melanie T Jaeger, et al.
International Journal of Cancer|February 2, 2008
Targeting prostate cancer with HTI-286, a synthetic analog of the marine sponge product hemiasterlinBoris A Hadaschik, Susan Ettinger, Richard D Sowery, et al.
BJU International|March 14, 2008
Clusterin knockdown using the antisense oligonucleotide OGX-011 re-sensitizes docetaxel-refractory prostate cancer PC-3 cells to chemotherapyRichard D Sowery, Boris A Hadaschik, Alan I So, et al.
BJU International|April 4, 2008
Paclitaxel and cisplatin as intravesical agents against non-muscle-invasive bladder cancerBoris A Hadaschik, Melanie G ter Borg, John Jackson, et al.
Pageof 1